Carregant...

ASSOCIATION BETWEEN THE INTRODUCTION OF A NEW CYSTIC FIBROSIS INHALED ANTIBIOTIC CLASS AND CHANGE IN PREVALENCE OF PATIENTS RECEIVING MULTIPLE INHALED ANTIBIOTIC CLASSES

BACKGROUND: In 2010, aztreonam for inhalation solution joined aminoglycosides and colistimethate as a new cystic fibrosis (CF) chronic inhaled antimicrobial therapy. We studied how introduction of this new inhaled antibiotic class changed management of US CF patients. METHODS: Use of inhaled aminogl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cyst Fibros
Autors principals: Dasenbrook, Elliott C., Konstan, Michael W., VanDevanter, Donald R.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417393/
https://ncbi.nlm.nih.gov/pubmed/25496726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2014.11.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!